1. Home
  2. JYNT vs XGN Comparison

JYNT vs XGN Comparison

Compare JYNT & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • XGN
  • Stock Information
  • Founded
  • JYNT 2010
  • XGN 2002
  • Country
  • JYNT United States
  • XGN United States
  • Employees
  • JYNT N/A
  • XGN N/A
  • Industry
  • JYNT Multi-Sector Companies
  • XGN Medical Specialities
  • Sector
  • JYNT Miscellaneous
  • XGN Health Care
  • Exchange
  • JYNT Nasdaq
  • XGN Nasdaq
  • Market Cap
  • JYNT 170.3M
  • XGN 138.3M
  • IPO Year
  • JYNT 2014
  • XGN 2019
  • Fundamental
  • Price
  • JYNT $9.98
  • XGN $9.31
  • Analyst Decision
  • JYNT Strong Buy
  • XGN Strong Buy
  • Analyst Count
  • JYNT 3
  • XGN 5
  • Target Price
  • JYNT $16.33
  • XGN $12.40
  • AVG Volume (30 Days)
  • JYNT 88.4K
  • XGN 210.4K
  • Earning Date
  • JYNT 11-06-2025
  • XGN 11-11-2025
  • Dividend Yield
  • JYNT N/A
  • XGN N/A
  • EPS Growth
  • JYNT N/A
  • XGN N/A
  • EPS
  • JYNT N/A
  • XGN N/A
  • Revenue
  • JYNT $53,449,713.00
  • XGN $58,862,000.00
  • Revenue This Year
  • JYNT $8.06
  • XGN $22.09
  • Revenue Next Year
  • JYNT $11.18
  • XGN $13.62
  • P/E Ratio
  • JYNT N/A
  • XGN N/A
  • Revenue Growth
  • JYNT 277.36
  • XGN 3.89
  • 52 Week Low
  • JYNT $9.58
  • XGN $2.38
  • 52 Week High
  • JYNT $13.47
  • XGN $10.34
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 30.53
  • XGN 47.62
  • Support Level
  • JYNT $10.47
  • XGN $9.55
  • Resistance Level
  • JYNT $10.74
  • XGN $10.28
  • Average True Range (ATR)
  • JYNT 0.22
  • XGN 0.39
  • MACD
  • JYNT -0.05
  • XGN -0.11
  • Stochastic Oscillator
  • JYNT 8.33
  • XGN 11.81

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: